Three gene sets could predict response to rheumatoid arthritis therapies
Monday, November 14, 2016 - 13:01
in Health & Medicine
Three gene expression signatures can help rheumatologists predict which patients are more likely to respond to tumor necrosis factor inhibitors (TNFi) or B-cell depletion therapies in patients with moderate to severe rheumatoid arthritis.